Passing a standard annual checkup with flying colors doesn’t guarantee protection from heart disease.
In a recent video, Dr. Lean Kim, a double board-certified physician specializing in longevity and metabolic health, revealed why seemingly healthy people with normal cholesterol levels still suffer heart attacks.
The problem lies in what routine screenings don’t measure—hidden risk factors that silently build cardiovascular danger for decades.
Understanding these overlooked markers could be the difference between prevention and catastrophe.
Jump to:
Inflammation: The Silent Killer Hiding in Plain Sight
Cholesterol management alone won’t save you from a heart attack. Recent research makes this abundantly clear: inflammation matters just as much as cholesterol, if not more.
The landmark CANTOS trial enrolled over 10,000 patients with existing heart disease whose LDL cholesterol was already well-controlled at a median of just 82 mg/dL. Their cholesterol wasn’t the problem—their inflammation was.
Researchers measured inflammation using high-sensitivity C-reactive protein (hs-CRP) and asked a simple question: what happens when you lower inflammation without touching cholesterol at all?
The results were striking. By blocking a specific inflammatory pathway with medication that had zero effect on cholesterol, major cardiovascular events dropped by 15%. Patients who brought their hs-CRP below 2 mg/L saw even better results: a 25% reduction in major cardiac events and a 31% reduction in death from any cause.
A larger collaborative analysis of over 31,000 patients already taking statins confirmed the pattern. Even with treated LDL levels, those with hs-CRP above 2 mg/L faced double the risk of cardiovascular death compared to people with low inflammation.
Dr. Kim emphasizes that this doesn’t mean LDL should be ignored—it remains a causative factor in plaque buildup. But cholesterol and inflammation are separate problems requiring separate solutions.
The American College of Cardiology agrees. They issued a scientific statement confirming that hs-CRP predicts cardiovascular risk as well as, and sometimes better than, standard cholesterol numbers.
Root Causes Worth Investigating
When Dr. Kim finds elevated hs-CRP in patients, she always searches for the underlying cause. Common culprits include:
- Excess visceral fat accumulation around organs
- Insulin resistance and metabolic dysfunction
- Poor sleep quality or insufficient sleep duration
- Chronic stress that never gets addressed
- Untreated dental issues causing systemic inflammation
The encouraging news? Most of these factors are fixable. When you address the root problem, inflammation drops—and cardiovascular risk plummets with it.
Why Standard LDL Testing Misses Half the Picture
Most doctors check LDL cholesterol (LDL-C) during annual physicals. It’s a decent marker, but it doesn’t reveal the complete story.
LDL is just one type of lipoprotein that carries cholesterol from the liver to tissues. Other dangerous players exist: VLDL (very low-density lipoprotein) and IDL (intermediate-density lipoprotein) also drive plaque formation.
This means you can have “normal” LDL but still face significant risk from these other particles.
ApoB: Counting Every Dangerous Particle
Apolipoprotein B (ApoB) offers a far more accurate risk assessment. Each cholesterol-carrying particle—whether LDL, IDL, or VLDL—has exactly one ApoB molecule attached to it.
When you measure ApoB, you’re counting every atherogenic particle in your bloodstream, capturing the entirety of the risk.
For most people, ApoB and LDL move together. High LDL usually means high ApoB; low LDL typically indicates low ApoB. But discrepancies emerge in people with insulin resistance—including those with prediabetes, type 2 diabetes, fatty liver, PCOS, or hypertension.
This creates a major blind spot. Up to 40% of the U.S. population without diabetes has insulin resistance, making ApoB testing critically important for millions who think their “normal” LDL means they’re safe.
The 10-Year Risk Calculator Trap
Most physicians use the ASCVD risk calculator, which estimates heart attack or stroke probability over the next decade. Low risk on this calculator typically earns patients a reassuring “see you next year.”
But atherosclerosis doesn’t develop in 10 years. Plaque formation begins as early as adolescence, visible even in teenagers and young adults. It accumulates silently over 30 to 40 years before triggering a heart attack, usually in someone’s 60s or 70s.
By the time the 10-year calculator flashes a warning, plaque has been building for decades—and reversing it becomes exponentially harder.
I think of it like driving in full speed toward a cliff and only hitting the brakes when you’re right at the edge. But then you run out of the road and it’s very hard to stop before you fall off and have a heart attack.
Dr. Kim takes a different approach with her patients: thinking in terms of 30 to 40 years instead of the next decade.
Aggressive ApoB Targets for Long-Term Protection
For meaningful cardiovascular protection over decades, Dr. Kim recommends getting ApoB below the fifth percentile of the population—roughly below 60 mg/dL.
When relying on LDL instead, the target is below 60-70 mg/dL, the threshold at which research shows plaque development begins.
These targets sound aggressive compared to typical primary care recommendations, but the math changes completely when prevention spans decades rather than years.
Lipoprotein(a): The Genetic Time Bomb
About one in five people carry a genetic marker that can double or triple heart attack risk—and it never appears on standard cholesterol panels.
Lipoprotein(a), or Lp(a), is probably the most common reason seemingly healthy people in their 40s suffer heart attacks or strokes without warning.
What makes elevated Lp(a) so dangerous is its genetic origin. You can’t meaningfully lower it through diet and exercise. Most people discover they have it only after something catastrophic happens.
Why Lp(a) Causes So Much Damage
Structurally similar to LDL, Lp(a) has an extra protein wrapped around it that makes it far more dangerous. This structure accelerates plaque formation and increases the likelihood of plaque rupture and clot formation.
Additionally, Lp(a) drives calcium buildup on the aortic valve, leading to aortic stenosis—a condition where calcium accumulation makes the valve stiff and narrow. Over years, this causes heart failure and serious blood flow problems.
The American Heart Association now recommends all adults get Lp(a) checked at least once in their lifetime. Since it’s genetic and remains stable throughout life, one test is sufficient—but you absolutely need to know your number.
Managing Elevated Lp(a) Now
No FDA-approved medications currently exist for lowering Lp(a), though several therapies in phase three trials show promising results. Effective treatments appear imminent.
Meanwhile, the strategy focuses on aggressively lowering overall cardiovascular risk through controllable factors:
- Getting ApoB as low as possible
- Maintaining controlled blood pressure
- Addressing insulin resistance
- Reducing systemic inflammation
Insulin Resistance: The Root Cause Behind Multiple Risk Factors
Insulin resistance might be the biggest driver of heart disease in people who otherwise look healthy on paper—potentially more significant than cholesterol itself.
In the Quebec Cardiovascular Study, people with high insulin levels faced more than five times the risk of heart disease compared to those with normal insulin. This dwarfed the risk from high LDL or high ApoB.
Even more telling: men with normal cholesterol but high insulin levels still had elevated heart disease risk.
Insulin resistance manifests as fatty liver, high blood pressure, prediabetes (eventually progressing to type 2 diabetes), PCOS, and elevated triglycerides. It makes ApoB a much better predictor than LDL alone.
The Hidden Compensation Your Doctor Misses
Here’s what makes insulin resistance so easy to overlook: fasting blood sugar and A1C can appear completely normal while significant insulin resistance exists underneath.
Doctors see those normal numbers and declare everything fine. What those tests don’t reveal is how much harder your pancreas works to maintain those numbers.
If your blood sugar is only normal because your pancreas is working three times as hard as it should be, that’s not health. That’s compensation.
That compensation comes at a steep cost.
Testing That Catches Insulin Resistance Early
Ask your doctor to check fasting insulin levels alongside fasting glucose and A1C. High insulin while glucose remains normal signals that your pancreas is already working overtime.
The encouraging news: insulin resistance is reversible, especially when caught early. When you fix it, almost every cardiovascular risk improves simultaneously—ApoB drops, triglycerides improve, blood pressure normalizes, and inflammation resolves.
The fundamental interventions are straightforward:
- Reduce visceral fat through sustainable weight loss
- Emphasize both regular aerobic and resistance training
- Cut back on refined carbohydrates and ultra-processed foods
For many patients, these steps alone produce dramatic improvements within just a few months.
Beyond Blood Tests: The Imaging Piece
All these tests—ApoB, Lp(a), fasting insulin, and hs-CRP—are blood markers indicating how favorable or unfavorable your biology is for plaque formation.
But they don’t actually show whether plaque has already started building. For that, imaging becomes essential.
Tools like coronary artery calcium scoring (CAC), coronary CT angiography, and carotid intima-media thickness (CIMT) ultrasound each reveal different aspects of cardiovascular health and prove useful in different clinical situations.
Dr. Kim is preparing a dedicated video exploring exactly which imaging tests to request and how to interpret them—critical information for anyone serious about long-term heart health.
